Table 2

Clinical outcomes in OSA versus non-OSA groups according to diabetes status

VariablesDiabetesNo diabetes
Unadjusted HR
(95% CI)
P valueAdjusted HR*
(95% CI)
P valueUnadjusted HR
(95% CI)
P valueAdjusted HR*
(95% CI)
P value
MACCE2.89 (1.36 to 6.17)0.0062.49 (1.16 to 5.35)0.021.06 (0.59 to 1.90)0.850.94 (0.51 to 1.75)0.85
 Cardiovascular death†5.11 (0.60 to 43.77)0.140.25
 Myocardial infarction†2.75 (0.28 to 26.72)0.380.16 (0.02 to 1.31)0.09
 Stroke†3.98 (0.44 to 35.73)0.220.95 (0.13 to 6.74)0.96
 Ischemia-driven revascularization1.52 (0.50 to 4.66)0.471.50 (0.48 to 4.68)0.491.64 (0.55 to 4.89)0.381.35 (0.42 to 4.30)0.62
 Hospitalization for unstable angina2.49 (0.97 to 6.38)0.062.41 (0.93 to 6.26)0.071.56 (0.71 to 3.40)0.271.45 (0.64 to 3.33)0.38
 Hospitalization for heart failure†0.610.64 (0.11 to 3.85)0.63
All repeat revascularization1.81 (0.67 to 4.90)0.251.86 (0.68 to 5.14)0.231.13 (0.56 to 2.28)0.741.08 (0.51 to 2.28)0.85
Composite of all events2.89 (1.40 to 5.93)0.0042.52 (1.21 to 5.22)0.011.02 (0.62 to 1.67)0.940.95 (0.56 to 1.62)0.86
  • *Model adjusted for age, sex, body mass index, hypertension, and diabetes mellitus, clinical presentation (acute myocardial infarction vs unstable angina).

  • †Univariate and/or multivariate Cox regression was not done due to no or few number of events.

  • MACCE, major adverse cardiovascular and cerebrovascular event; OSA, obstructive sleep apnea.